Allergic bronchopulmonary aspergillosis presumably unmasked by PD-1 inhibition.
Programmed cell death-1 (PD-1) inhibitors stimulate immune recognition of tumour cells in cancer patients, but have significant autoimmune side effects including pneumonitis. We report the case of a patient with asthma and mild eosinophilia who developed unusual pulmonary side effect of bronchiectasis, severe eosinophilia (absolute eosinophil count: 3200 c/mm
BMJ Case Rep
Donato, A., & Krol, R. (2019). Allergic bronchopulmonary aspergillosis presumably unmasked by PD-1 inhibition.. BMJ Case Rep, 12 (2) https://doi.org/10.1136/bcr-2018-227814